Skip to main content
SpringerLink
Log in
Book cover

Controlled Pulmonary Drug Delivery pp 265–282Cite as

Polymers for Pulmonary Drug Delivery

  • Chapter
  • First Online:

Part of the book series: Advances in Delivery Science and Technology ((ADST))

Abstract

One method by which to modify the release rate of a drug in the pulmonary tract, is through the use of polymeric systems. There are several natural and synthetic polymers that have been studied in vitro or in vivo in animals to assess pulmonary drug delivery and sustained release. This chapter focuses on some of the more common non-conjugated polymers utilized for inhalation drug delivery and draws examples from an array of pre-clinical findings.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Adi H, Young PM, Chan H, Salama R, Traini D (2010) Controlled release antibiotics for dry powder lung delivery. Drug Dev Ind Pharm 36:119–126

    Article  CAS  Google Scholar 

  2. Alhusban FA, Seville PC (2009) Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulfate. J Microencapsul 26:444–455

    Article  PubMed  CAS  Google Scholar 

  3. Amecke B, Bendix D, Entenmann G (1992) Resorbable polyesters: composition, properties, and applications. Clin Mater 10:47–50

    Article  PubMed  CAS  Google Scholar 

  4. Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C (2007) NanoCipro encapsulation in monodisperse large porous PLGA microparticle. J Control Release 121:100–109

    Article  PubMed  CAS  Google Scholar 

  5. Bailey MM, Berkland CJ (2009) Nanoparticle formulations in pulmonary drug delivery. Med Res Rev 29:196–212

    Article  PubMed  CAS  Google Scholar 

  6. Brannon-Peppas L (1997) Polymers in controlled drug delivery. Med Plast Biomater 4:34–44

    Google Scholar 

  7. Cook RO, Pannu RK, Kellaway IW (2005) Novel sustained release microspheres for pulmonary drug delivery. J Control Release 104:79–90

    Article  PubMed  CAS  Google Scholar 

  8. Coowanitwong I, Arya V, Kulvanich P, Hochhaus G (2008) Slow release formulations of inhaled rifampin. AAPS J 10:342–348

    Article  PubMed  CAS  Google Scholar 

  9. Courrier HM, Butz N, Vandamme TF (2002) Pulmonary drug delivery systems: recent development and prospectives. Crit Rev Therap Drug Carrier Syst 19:425–498

    Article  CAS  Google Scholar 

  10. Donovan M, McGill S, Smyth H (2008) Swellable particles for sustained release drug delivery to the lungs. Respir Drug Deliv 3:857–860

    Google Scholar 

  11. Edwards DA, Ben-Jebria A, Langer R (1998) Recent advances in pulmonary drug delivery using large, porous inhaled particles. J Appl Physiol 85:379–385

    PubMed  CAS  Google Scholar 

  12. Edwards DA, Hanes J, Caponetti G, Hrkach K, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R (1997) Large porous particles for pulmonary drug delivery. Science 276:1868–1871

    Article  PubMed  CAS  Google Scholar 

  13. El-Baseir MM, Kellaway IW (1998) Poly(L-lactic acid) microspheres for pulmonary drug delivery: release kinetics and aerosolization studies. Int J Pharm 175:135–145

    Article  PubMed  CAS  Google Scholar 

  14. Fu J, Fiegel J, Hanes J (2004) Synthesis and characterization of PEG-based ether anhydride terpolymers: novel polymers for controlled drug release. Macromolecules 37:7174–7180

    Article  CAS  Google Scholar 

  15. Fu J, Fiegel J, Krauland E, Hanes J (2002) New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 23:4425–4433

    Article  PubMed  CAS  Google Scholar 

  16. Garcia-Contreras L, Morçöl T, Bell SJD, Hickey AJ (2003) Evaluation of novel particles as pulmonary delivery systems for insulin in rats. AAPS Pharm Sci 5(2):article 9

    Article  Google Scholar 

  17. Hickey AJ, Suarez S, Bhat M, O’Hara P, Lalor CB, Atkins K, Hopfer R, McMurry DN (1998) Efficacy of rifampicin-poly(lactide-co-glycolide) microspheres in treating tuberculosis. Respir Drug Deliv VI 1:201–209

    Google Scholar 

  18. Jaspart S, Bertholet P, Piel G, Dogné J, Delattre L, Evrard B (2007) Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm 65:47–56

    Article  PubMed  CAS  Google Scholar 

  19. Kawashima Y, Yamamoto H, Takeuchi H, Fujioka S, Hino T (1999) Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. J Control Release 62:279–287

    Article  PubMed  CAS  Google Scholar 

  20. Koushik K, Dhanda DS, Cheruvu NPS, Kompella UB (2004) Pulmonary delivery of deslorelin: large-porous PLGA particles and HPβCD complexes. Pharm Res 21:1119–1126

    Article  PubMed  CAS  Google Scholar 

  21. Leach CL, Mameister WM, Tomai MA, Hammerbeck DM, Stefely JS (2000) Oligolactic acid (OLA) biomatricies for sustained release of asthma therapeutics. Respir Drug Deliv VII 2:291–294

    Google Scholar 

  22. Learoyd TP, Burrows JL, French E, Seville PC (2006) Leucine-modified PLGA-based respirable spray-dried powders for sustained drug delivery. Respir Drug Deliv 2:437–440

    Google Scholar 

  23. Learoyd TP, Burrows JL, French E, Seville PC (2006) Sustained drug delivery from chitosan-based respirable spray-dried powders. Respir Drug Deliv 2:441–443

    Google Scholar 

  24. Learoyd TP, Burrows JL, French E, Seville PC (2008) Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm 68:224–234

    Article  PubMed  CAS  Google Scholar 

  25. Learoyd TP, Burrows JL, French E, Seville PC (2009) Sustained delivery by leucine modified chitosan spray-dried respirable powders. Int J Pharm 372:97–104

    Article  PubMed  CAS  Google Scholar 

  26. Li FQ, Hu JH, Lu B, Yao H, Zhang WG (2001) Ciprofloxacin-loaded bovine serum albumin microspheres: Preparation and drug-release in vitro. J Microencapsul 18:825–829

    Article  PubMed  CAS  Google Scholar 

  27. Li Z, Stefely JS (2004) Aerosol sustained release formulations with oligolactic acid (OLA). Respir Drug Deliv IX 2:321–324

    Google Scholar 

  28. Louey MD, Garcia-Contreras L (2004) Controlled release products for respiratory delivery. Am Pharm Rev 7:82–87

    CAS  Google Scholar 

  29. Lu B, Zhang Q, Yang H (2003) Lung-targeting microspheres of carboplatin. Int J Pharm 265:1–11

    Article  PubMed  CAS  Google Scholar 

  30. Lu D, Garcia-Contreras L, Xu D, Kurtz SL, Liu J, Braunstein M, McMurray DN, Hickey AJ (2007) Poly (lactide-c-glycolide) microspheres in respirable sizes enhance an in vitro T cell response to Mycobacterium tuberculosis antigen 85B. Pharm Res 24:1834–1843

    Article  PubMed  CAS  Google Scholar 

  31. Morimoto K, Katsumata H, Yabuta T, Iwanaga K, Kakemi M, Tabata Y, Ikada Y (2002) Gelatin microsphere as a pulmonary delivery system: evaluation of salmon calcitonin absorption. J Pharm Pharmacol 52:611–617

    Article  Google Scholar 

  32. Morimoto K, Metsugi K, Katsumata H, Iwanaga K, Kakemi M (2001) Effects of low-viscosity sodium hyaluronate preparation on pulmonary absorption of rh-insulin in rats. Drug Dev Ind Pharm 27:365–371

    Article  PubMed  CAS  Google Scholar 

  33. Mu L, Feng SS (2001) Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by pray drying technique with lipid/cholesterol emulsifiers. J Control Release 76:239–254

    Article  PubMed  CAS  Google Scholar 

  34. Müller RH, Maaβen S, Wayhers H, Specht F, Lucks JS (1996) Cyctotoxcity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 138:85–94

    Article  Google Scholar 

  35. Nah J, Jeong Y, Cho C, Kim S (2000) Drug-delivery system based on core-shell type nanoparticles composed of poly(γ-benzyl-L-glutamate) and poly(ethylene oxide). J Appl Polym Sci 75:1115–1126

    Article  CAS  Google Scholar 

  36. Naikwade S, Bajaj A (2009) Preparation and in vitro evaluation of budesonide spray dried microparticles for pulmonary delivery. Sci Pharm 77:419–441

    Article  CAS  Google Scholar 

  37. Oyarzun-Ampuero FA, Brea J, Loza MI, Torres D, Alonso MJ (2009) Chitosan hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm 381:122–129

    Article  PubMed  CAS  Google Scholar 

  38. Pulapura S, Kohn J (1992) Trends in the development of bioresorbable polymers for medical applications. J Biomater Appl 6:215–250

    Article  Google Scholar 

  39. Rouse JJ, Whateley TL, Thomas M, Ecclecston GM (2007) Controlled drug delivery to the lungs: Influence of hyaluronic acid solution conformation on its adsorption to hydrophobic drug particles. Int J Pharm 330:175–182

    Article  PubMed  CAS  Google Scholar 

  40. Ruan G, Feng S (2003) Preparation and characterization of poly(lactic acid) poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. Biomaterials 24:5037–5044

    Article  PubMed  CAS  Google Scholar 

  41. Salama RO, Traini D, Chan H, Sung A, Ammit AJ, Young PM (2009) Preparation and evaluation of controlled release microparticles for respiratory protein therapy. J Pharm Sci 98:2709–2717

    Article  PubMed  CAS  Google Scholar 

  42. Salama R, Traini D, Chan H, Young PM (2009) Recent advances in controlled release pulmonary therapy. Curr Drug Deliv 6:404–414

    Article  PubMed  CAS  Google Scholar 

  43. Salama RO, Traini D, Chan H, Young PM (2008) Preparation and characterisation of controlled release co-spray dried drug-polymer microparticles for inhalation 2: evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm 70:145–152

    Article  PubMed  CAS  Google Scholar 

  44. Schliecker G, Schmidt G, Fusch S, Wombacher R, Kissel T (2003) Hydrolytic degradation of poly(lactide-co-glycolide) films: effect of oligomers on degradation rate and crystallinity. Int J Pharm 266:39–49

    Article  PubMed  CAS  Google Scholar 

  45. Shi S, Hickey AJ (2010) PLGA microparticles in respirable sizes enhance an in vitro T cell response to recombinant Mycobacterium tuberculosis antigen TB10.4-Ag58B. Pharm Res 27:350–360

    Article  PubMed  CAS  Google Scholar 

  46. Shoyele SA (2008) Controlling the release of proteins/peptides via the pulmonary route. Drug Deliv Syst 437:141–148

    Article  CAS  Google Scholar 

  47. Suarez S, O’Hara P, Kazantseva M, Newcomer CE, Hopfer R, McMurray DN, Hickey AJ (2001) Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model. Pharm Res 18:1315–1319

    Article  PubMed  CAS  Google Scholar 

  48. Sung JC, Pulliam BL, Edwards DA (2007) Nanoparticles for drug delivery to the lungs. Trends Biotechnol 25:563–570

    Article  PubMed  CAS  Google Scholar 

  49. Sung JC, Padilla DJ, Garcia-Contreras L, VerBerkmoes JL, Durbin D, Peloquin CA, Elbert KJ, Hickey AJ, Edwards DA (2009) Formulation and pharmacokinetics of self-assembled rifampicin nanoparticle systems for pulmonary delivery. Pharm Res 26:1847–1855

    Article  PubMed  CAS  Google Scholar 

  50. Surendrakumar K, Martyn GP, Hodgers ECM, Jansen M, Blair JA (2003) Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery of beagle dogs. J Control Release 91:385–394

    Article  PubMed  CAS  Google Scholar 

  51. Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y (2009) Improved cellular update of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 382:198–204

    Article  PubMed  CAS  Google Scholar 

  52. Takeuchi H, Yamamoto H, Kawashima Y (2001) Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 47:39–54

    Article  PubMed  CAS  Google Scholar 

  53. Tomoda K, Ohkoshi T, Hirota K, Sonavane GS, Nakajima T, Terada H, Komuro M, Kitazota K, Makino K (2009) Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer. Colloids Surf B Biointerfaces 17:177–182

    Article  Google Scholar 

  54. Wang C, Muttil P, Lu D, Beltran-Torres AA, Garcia-Contreras L, Hickey AJ (2009) Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines. AAPS J 11:139147

    Google Scholar 

  55. Wischke C, Schwendeman SP (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 364:298–327

    Article  PubMed  CAS  Google Scholar 

  56. Wu L, da Rocha SRP (2007) Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation. Langmuir 23:12104–12110

    Article  PubMed  CAS  Google Scholar 

  57. Yamada K, Kamada N, Odomi M, Okada N, Nabe T, Fujita T, Kohno S, Yamamoto A (2005) Carrageenans can regulate the pulmonary absorption of antiasthmatic drugs and their retention in the rat lung tissues without any membrane damage. Int J Pharm 293:63–72

    Article  PubMed  CAS  Google Scholar 

  58. Yamada K (2007) Control of pulmonary absorption of drugs by various pharmaceutical excipients. Yakugaku Zasshi 127:631–641

    Article  PubMed  CAS  Google Scholar 

  59. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y (2005) Surface modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin in mucoadhesion and opening of the intracellular tight space. J Control Release 102:373–381

    Article  PubMed  CAS  Google Scholar 

  60. Yang Y, Bajaj N, Xu P, Ohn K, Tsifansky MD, Yeo Y (2009) Development of highly porous large PLGA microparticles for pulmonary drug delivery. Biomaterials 30:1947–1953

    Article  PubMed  CAS  Google Scholar 

  61. Zhang Q, Shen Z, Nagai T (2001) Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats. Int J Pharm 218:75–80

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Arizona, 1703 East Mabel Street, Tucson, AZ, 85721, USA

    Paul B. Myrdal

Authors
  1. Poonam Sheth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul B. Myrdal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul B. Myrdal .

Editor information

Editors and Affiliations

  1. , Pharmaceutics Division - PHR 4.214, University of Texas, University Station 1, Austin, 78712, USA

    Hugh D.C. Smyth

  2. Eshelman School of Pharmacy, Division of Molecular Pharmaceutics, University of North Carolina, Chapel Hill, 27599, North Carolina, USA

    Anthony J. Hickey

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Controlled Release Society

About this chapter

Cite this chapter

Sheth, P., Myrdal, P.B. (2011). Polymers for Pulmonary Drug Delivery. In: Smyth, H., Hickey, A. (eds) Controlled Pulmonary Drug Delivery. Advances in Delivery Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-9745-6_12

Download citation

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation